The Many Risk Factors of Prostate Cancer

Nobody wants to get cancer. That being said, we should all be aware of what the risk factors are for certain cancers. If you think you are at a higher risk for a specific type of cancer you should become familiar with what factors tend to increase the likelihood that you will develop the disease. Say, for instance, that prostate cancer runs in your family. You should know that there are many different factors that increase your risk, especially since there are some factors that you have control over.

There are several main factors that you do not have control over. One of those factors is your age. Men over the age of 50 have a higher chance of being diagnosed with this cancer. More than 70 percent of men with prostate cancer are over the age of 65. Race is another factor that you cannot control. Prostate cancer is 60 percent more common among African-American men than among Caucasian men. If you have a family history of this disease, you definitely have an increased risk of developing the disease yourself. A man’s risk of developing it is more than doubled if he has a father or brother that has the disease. Although, just because a relative has prostate cancer, it doesn’t mean that you necessarily will get it as well. Sometimes the cancer is simply sporadic, meaning that it can develop in one male relative, but not another. Only five to ten percent of those cases are determined to be hereditary. This would be a family with three or more affected relatives within the immediate family or a family where each of three generations are affected.

» Read more: The Many Risk Factors of Prostate Cancer

Related posts

Drug Shrinks Lung Cancer Tumors In Mice

One in five people with lung cancer have small cell lung cancer and only three per cent of these people are expected to survive for five years. With this form of lung cancer, tumours spread quickly so it is rarely possible to remove the tumours surgically. Because of this, small cell lung cancer is treated with chemotherapy, with or without additional radiotherapy. Initially, the treatment often appears to work, reducing the size of the tumours. However, the tumours usually grow back rapidly and then become resistant to further treatment.

The researchers behind today’s study have identified a drug that, in some mice, was able to completely shrink tumours away. In the mouse models, it was also able to stop tumours from growing and it helped other forms of chemotherapy to work more effectively. If the drug proves successful in humans, the researchers hope that it could help patients with this kind of lung cancer to live longer.

» Read more: Drug Shrinks Lung Cancer Tumors In Mice

Related posts

Markers for Ovarian Cancer May Show Up Years Earlier

Markers for Ovarian Cancer May Show Up Years Earlier
TUESDAY, Jan. 5 (HealthDay News) — Concentrations of several biomarkers begin to grow three years before women are diagnosed with ovarian cancer, but only reach substantial elevation levels over the 12 months before diagnosis, new research finds.

Read more on HealthDay via Yahoo! News

Related posts